POINT Biopharma Global In... (PNT)

AI Score

Unlock

12.50

0.02 (0.16%)

At close: Dec 26, 2023, 9:00 PM

POINT Biopharma Global Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Revenue	243.69M	240.9M	236.04M	226.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	-9.45B	-9.45B	-9.45B	n/a	n/a	n/a	n/a	n/a	n/a	168.31K	168.31K	168.31K	168.31K	n/a
Gross Profit	9.69B	9.69B	9.68B	226.58M	n/a	n/a	n/a	n/a	n/a	-168.31K	-168.31K	-168.31K	-168.31K	n/a
Operating Income	107.77M	112.76M	119.37M	125.52M	-79.94M	-72.33M	-56.09M	-45.51M	-36.82M	-22.86M	-17.44M	-11.71M	-6.3M	-3.23M
Interest Income	n/a	n/a	509.7K	557.67K	557.67K	557.67K	47.97K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	127.1M	127.17M	129.11M	129.59M	-78.66M	-71.86M	-56.15M	-45.6M	-37M	-23.01M	-17.46M	-11.72M	-6.18M	-3.13M
Net Income	96.55M	97.31M	98.14M	98.29M	-79.17M	-72.27M	-56.5M	-45.9M	-37.26M	-23.19M	-17.57M	-11.79M	-6.24M	-3.19M
Selling & General & Admin	22.88M	21.22M	20.21M	19.01M	16.29M	16.48M	14.35M	12.01M	8.73M	5.3M	4.41M	2.95M	1.66M	1.07M
Research & Development	113.04M	106.92M	96.46M	82.05M	63.64M	55.85M	41.74M	33.51M	28.09M	17.57M	13.03M	8.76M	4.64M	2.16M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	135.92M	128.14M	116.67M	101.06M	79.94M	72.33M	56.09M	45.51M	36.82M	22.86M	17.44M	11.71M	6.3M	3.23M
Interest Expense	n/a	1.05M	1.56M	1.61M	1.65M	604.1K	97.27K	52.09K	14.69K	11.02K	8.15K	5.35K	2.51K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	135.92M	128.14M	116.67M	101.06M	79.94M	72.33M	56.09M	45.51M	36.82M	22.86M	17.44M	11.71M	6.3M	3.23M
Income Tax Expense	30.55M	29.86M	30.97M	31.29M	512.43K	412.97K	353.35K	305.66K	259.63K	178.58K	113.06K	72.64K	58.26K	58.26K
Shares Outstanding (Basic)	105.77M	105.72M	105.66M	96.03M	92.4M	90.12M	90.12M	90.12M	90.12M	57.58M	56.67M	17M	54.18M	90.12M
Shares Outstanding (Diluted)	105.77M	105.72M	105.66M	96.03M	92.4M	90.12M	90.12M	90.12M	90.12M	57.58M	56.67M	17M	54.18M	90.12M
EPS (Basic)	1.10	1.07	1.04	1.02	-0.87	-0.8	-0.68	-0.6	-0.77	-0.64	-0.52	-0.42	-0.09	-0.04
EPS (Diluted)	1.07	1.04	1.01	0.99	-0.87	-0.8	-0.68	-0.6	-0.77	-0.64	-0.52	-0.42	-0.09	-0.04
EBITDA	93.91M	104.4M	115.76M	127.32M	-78.67M	-71.7M	-55.83M	-45.51M	-36.82M	-22.86M	-17.44M	-11.71M	-6.3M	-3.23M
EBIT	-5.99B	-6.02B	-6.04B	130.78M	-62.92M	-57.16M	-41.95M	-31.45M	-36.98M	-23M	-14.32M	-8.58M	-3.04M	n/a
Depreciation & Amortization	-2.98M	-3.2M	-3.61M	1.8M	1.23M	641.72K	325.43K	124.77K	220.15K	3.38M	3.38M	3.32M	3.27M	51.12K